Sign up to save your podcasts
Or
Share E56-C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy- Dr. Kourous Rezaei
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E56-C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy- Dr. Kourous Rezaei
Dr. Kourous Rezaei reviews the results of the GATHER1 trial on complement C5 inhibition for slowing down progression of geography atrophy in dry AMD.
References article:
Jaffe GJ, Westby K, Csaky KG, Monés J, Pearlman JA, Patel SS, Joondeph BC, Randolph J, Masonson H, Rezaei KA. C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial. Ophthalmology. 2021 Apr;128(4):576-586. doi: 10.1016/j.ophtha.2020.08.027. Epub 2020 Sep 1. PMID: 32882310.
View all episodes
By Keyvan Koushan, MD, FRCSC
4.4
1111 ratings
Dr. Kourous Rezaei reviews the results of the GATHER1 trial on complement C5 inhibition for slowing down progression of geography atrophy in dry AMD.
References article:
Jaffe GJ, Westby K, Csaky KG, Monés J, Pearlman JA, Patel SS, Joondeph BC, Randolph J, Masonson H, Rezaei KA. C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial. Ophthalmology. 2021 Apr;128(4):576-586. doi: 10.1016/j.ophtha.2020.08.027. Epub 2020 Sep 1. PMID: 32882310.
More shows like The Retina Channel Podcast
View all
Planet Money
30,795 Listeners
New Retina Radio by Eyetube
18 Listeners
Straight From The Cutter's Mouth: A Retina Podcast
97 Listeners
White Coat Investor Podcast
2,441 Listeners
The Daily
112,401 Listeners
Up First from NPR
56,702 Listeners
ESCRS Podcasts
2 Listeners
MedEdTalks - Ophthalmology
4 Listeners
Retina Synthesis
8 Listeners
Pupil Pod
10 Listeners
Experts InSight
50 Listeners
RETINA Journal Podcasts
11 Listeners
Knock Knock, Hi! with the Glaucomfleckens
465 Listeners
Ophthalmology Journal
19 Listeners
Talking Euretina
1 Listeners